In this Issue:
Suicide in patients with genitourinary malignancies
Cixutumumab plus ADT versus ADT alone
Lenalidomide for mCRPC
Molecular profiling of clinical prostate cancer specimens
Metformin use in prostate cancer
Enzalutamide in mCRPC
mpMRI: detection of radiorecurrent prostate cancer
Evaluation of models predicting insignificant prostate cancer
Outcomes of definitive local therapy in Gleason 8 vs 9-10 disease
Docetaxel rechallenge in mCRPC
Please login below to download this issue (PDF)